Risk-specific nosocomial infection rates
- 作者Adele Josephson; Lynne Karanfil; Helida Alonso; Angela Watson; Judith Blight
- 卷第91卷
- 印刷ISSN0002-9343
- 电子ISSN1555-7162
- 文件大小800.09KB
- 发表时间1991
- DOI10.1016/0002-9343(91)90358-5
Comparison of levalbuterol and racemic albuterol combined with ipratropium bromide in acute pediatric asthma: A randomized controlled trialMark E. Ralston; Michael S. Euwema; Kenneth R. Knecht; Timothy J. Ziolkowski; Timothy A. Coakley; Shane M. Cline · 2005
AN IN VITRO COMPARISON OF THE IMPACT OF JET NEBULIZER DESIGN ON THE AEROSOL CHARACTERISTICS OF ALBUTEROL, IPRATROPIUM BROMIDE, AND BUDESONIDENikander, Kurt; Ziegler, Lauren R. · Chest · 2006
Comparison of Ipratropium Bromide and Albuterol Sulfate Chlorofluorocarbon Metered-Dose Inhaler and Albuterol Hydrofluoroalkane Metered-Dose Inhaler in a Crossover Trial in Patients with Moderate-to-Severe AsthmaBleecker, E.R.; Busse, W.W.; Donohue, J.F.; Garfinkel, S.; Lystig, T.; Manuel, R.C.; Schlenker-Herceg, R.; Wise, R.A. · Journal of Allergy and Clinical Immunology · 2011
A Comparison of the Bronchodilating Effects of a Beta-2 Adrenergic Agent (Albuterol) and an Anticholinergic Agent (Ipratropium Bromide), Given by Aerosol Alone or in SequenceEaston, Paul A.; Jadue, Carlos; Dhingra, Saresh; Anthonisen, Nicholas R. · New England Journal of Medicine · 1986